NZ504194A - Physiologically acceptable aqueous solutions and methods for their use - Google Patents
Physiologically acceptable aqueous solutions and methods for their useInfo
- Publication number
- NZ504194A NZ504194A NZ504194A NZ50419497A NZ504194A NZ 504194 A NZ504194 A NZ 504194A NZ 504194 A NZ504194 A NZ 504194A NZ 50419497 A NZ50419497 A NZ 50419497A NZ 504194 A NZ504194 A NZ 504194A
- Authority
- NZ
- New Zealand
- Prior art keywords
- physiologically acceptable
- acceptable aqueous
- methods
- aqueous solutions
- oncotic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
An physiologically acceptable aqueous solution comprising: (1) electrolytes, (2) a dynamic buffering system, (3) at least one oncotic agent weight fraction of an initial oncotic agent source, wherein the weight fraction ranges from about 50 000 to 1 000 000 daltons. Wherein the solution comprises at least two of magnesium, a sugar in an amount of not more than about 50 mM and a medium or high molecular weight oncotic agent, and does not include a biological buffer. The described aqueous solution can be introduced into the circulatory system of a host as a plasma substitute solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ504194A NZ504194A (en) | 1997-10-31 | 1997-10-31 | Physiologically acceptable aqueous solutions and methods for their use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1997/019964 WO1999022746A1 (en) | 1997-10-31 | 1997-10-31 | Physiologically acceptable aqueous solutions and methods for their use |
NZ504194A NZ504194A (en) | 1997-10-31 | 1997-10-31 | Physiologically acceptable aqueous solutions and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ504194A true NZ504194A (en) | 2002-11-26 |
Family
ID=19927854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ504194A NZ504194A (en) | 1997-10-31 | 1997-10-31 | Physiologically acceptable aqueous solutions and methods for their use |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ504194A (en) |
-
1997
- 1997-10-31 NZ NZ504194A patent/NZ504194A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0861661A3 (en) | Method of providing an osmotic agent for a peritoneal dialysis solution | |
SG127714A1 (en) | Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes | |
GR3036013T3 (en) | Plasma-like solution | |
BR9814022A (en) | Detergent tablet | |
AU2525401A (en) | Use of an extract of at least one vaccinium-type plant as an anti-glycation agent | |
AU1745988A (en) | Skin treatment composition | |
HK1053986A1 (en) | Antiadhesive carbohydrates | |
AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
MY107276A (en) | Method and formulation employing type ii endoglycosidase | |
HK1012558A1 (en) | Thermally-gelling drug delivery vehicles containing cellulose ethers | |
NZ501386A (en) | Collagen from fish skin | |
WO2000033082A3 (en) | Methods for quantitation of hla-dr and cd11b | |
TW327602B (en) | A pharmaceutical composition of an ophthalmic suspension containing difluprednate | |
BR0213298A (en) | high protein formulations and manufacturing process | |
AU5579700A (en) | Stabilizer for pharmacons | |
PL314913A1 (en) | Prolongedly acting injectable suspensions and methodof obtaining same | |
AU1720697A (en) | Nutrient composition for exercise | |
EP0367271A3 (en) | Improved red blood cell preservative solution | |
NZ504194A (en) | Physiologically acceptable aqueous solutions and methods for their use | |
WO2000035372A3 (en) | Multiple matrices for engineered tissues | |
CA2260135A1 (en) | Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition | |
IL139283A0 (en) | Dextrin-containing composition for preventing surgical adhesions | |
BG104385A (en) | Physiologically acceptable aqueous solutions and methods for their application | |
AU5833694A (en) | Oligosaccharides having biological activity and preparation of same from glycosaminoglycans | |
EP0371733A3 (en) | Dopamine-beta-hydroxylase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |